Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug

Por Hyrich, K. L., Lunt, M., Dixon, W. G., Watson, K. D., Symmons, D. P. M.
Publicado em 2008

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics R...

Por Dixon, W G, Hyrich, K L, Watson, K D, Lunt, M, Symmons, D P M
Publicado em 2010

Serious Infection Following Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis: Lessons From Interpreting Data From Observational Studies

Por Dixon, W G, Symmons, D P M, Lunt, M, Watson, K D, Hyrich, K L, Silman, A J
Publicado em 2007

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for...

Por Dixon, W G, Watson, K D, Lunt, M, Hyrich, K L, Silman, A J, Symmons, D P M
Publicado em 2007

Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheu...

Por Dixon, W G, Watson, K D, Lunt, M, Mercer, L K, Hyrich, K L, Symmons, D P M
Publicado em 2010

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

Por Dixon, W G, Hyrich, K L, Watson, K D, Lunt, M, Galloway, J, Ustianowski, A, Symmons, D P M
Publicado em 2009

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Regi...

Por Harrison, M J, Dixon, W G, Watson, K D, King, Y, Groves, R, Hyrich, K L, Symmons, D P M
Publicado em 2008

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: r...

Por Bluett, J, Ibrahim, I, Plant, D, Hyrich, K L, Morgan, A W, Wilson, A G, Isaacs, J D, Barton, A
Publicado em 2014

Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

Por Galloway, J B, Hyrich, K L, Mercer, L K, Dixon, W G, Ustianowski, A P, Helbert, M, Watson, K D, Lunt, M, Symmons, D P M
Publicado em 2011

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis f...

Por Potter, C, Hyrich, K L, Tracey, A, Lunt, M, Plant, D, Symmons, D P M, Thomson, W, Worthington, J, Emery, P, Morgan, A W, Wilson, A G, Isaacs, J, Barton, A
Publicado em 2009